StreetInsider.com News Articles

CVS Health Earns Two Gold and One Silver Stevie(R) Awards for Great Employers

Tue, 11 Aug 2026 10:20:00 -0400

AI Learning Academy honored for building enterprise-wide AI literacy and colleague confidence

WOONSOCKET, RI / ACCESS Newswire / August 11, 2026 / Originally published on CVS Health Company Newsroom

CVS Health® (NYSE:CVS) announced that its AI Learning Academy earned two Golds and one Silver at the 11th Annual Stevie Awards for Great Employers, a global honor recognizing organizations for excellence in employee development, training and workplace culture. The company earned Gold in the Employee Upskill/Reskill Training and AI Workforce Innovation Team of the Year categories, and Silver in AI in Learning

CVS Health Earns Two Gold and One Silver Stevie(R) Awards for Great Employers

Tue, 11 Aug 2026 10:20:00 -0400

AI Learning Academy honored for building enterprise-wide AI literacy and colleague confidence

WOONSOCKET, RI / ACCESS Newswire / August 11, 2026 / Originally published on CVS Health Company Newsroom

Form 13F-HR CVS HEALTH Corp For: Jun 30

Thu, 06 Aug 2026 16:39:00 -0400

si-local-file:///var/storage/secattach/20260806/26884967.html

Form 13F-HR CVS HEALTH Corp For: Jun 30

Thu, 06 Aug 2026 16:39:00 -0400

si-local-file:///var/storage/secattach/20260806/26884967.html

CVS Health (CVS) PT Raised to $107 at Baird

Thu, 06 Aug 2026 08:29:31 -0400

Baird analyst Michael Ha raised the price target on CVS Health (NYSE: CVS) to $107.00 (from $94.00) while maintaining a Outperform rating.

CVS Health (CVS) PT Raised to $126 at UBS

Thu, 06 Aug 2026 06:17:51 -0400

UBS analyst Kevin Caliendo raised the price target on CVS Health (NYSE: CVS) to $126.00 (from $122.00) while maintaining a Buy rating.

The analyst comments "CVS management's incremental disclosures around 340B and selling season pressure in HSS soured what was a better-than-expected quarterly update and accelerated HCB margin recovery. Optically, the call outs at Caremark are not financially onerous, as other outperformance in the segment is an offset to the total segment AOI outlook. But this is the second straight year of Caremark issues, and as investors are getting increasingly comfortable with an improving PCW growth outlook (and valuation), PBM woes

CVS Health (CVS) PT Raised to $126 at UBS

Thu, 06 Aug 2026 06:17:51 -0400

UBS analyst Kevin Caliendo raised the price target on CVS Health (NYSE: CVS) to $126.00 (from $122.00) while maintaining a Buy rating.

CVS Health (CVS) PT Raised to $108 at Barclays

Thu, 06 Aug 2026 04:18:56 -0400

Barclays analyst Andrew Mok raised the price target on CVS Health (NYSE: CVS) to $108.00 (from $106.00) while maintaining a Overweight rating.

CVS shares jump on earnings beat, raised full-year guidance

Wed, 05 Aug 2026 06:45:58 -0400

Investing.com -- CVS Health shares jumped about 5% in premarket trading Wednesday after the company raised its full-year profit guidance following better-than-expected second-quarter results.

The healthcare group reported second-quarter earnings per share of $2.58, beating the analyst estimate of $1.83. Revenue rose 7.3% year-over-year to $106.1 billion, well ahead of the $100.03 billion consensus estimate.

Adjusted operating income climbed 35.5% year-over-year to $5.15 billion. Operating profit at the company’s health services unit, which includes its clinics, rose 10% to $1.73 billion from $1.58 billion, driven by changes to how CVS operates its Oak Street primary care business.

CVS also said its MinuteClinic will

CVS shares jump on earnings beat, raised full-year guidance

Wed, 05 Aug 2026 06:45:58 -0400

Investing.com -- CVS Health shares jumped about 5% in premarket trading Wednesday after the company raised its full-year profit guidance following better-than-expected second-quarter results.

CVS also said its MinuteClinic will

CVS shares jump on earnings beat, raised full-year guidance

Wed, 05 Aug 2026 06:45:58 -0400

Investing.com -- CVS Health shares jumped about 5% in premarket trading Wednesday after the company raised its full-year profit guidance following better-than-expected second-quarter results.

CVS also said its MinuteClinic will

Form 10-Q CVS HEALTH Corp For: Jun 30

Wed, 05 Aug 2026 06:34:00 -0400

si-local-file:///var/storage/secattach/20260805/26869740.html

Form 10-Q CVS HEALTH Corp For: Jun 30

Wed, 05 Aug 2026 06:34:00 -0400

si-local-file:///var/storage/secattach/20260805/26869740.html

CVS Health (CVS) Tops Q2 EPS by 75c; raises guidance

Wed, 05 Aug 2026 06:32:57 -0400

CVS Health (NYSE: CVS) reported Q2 EPS of $2.58, $0.75 better than the analyst estimate of $1.83. Revenue for the quarter came in at $106.1 billion versus the consensus estimate of $100.03 billion.

GUIDANCE:

CVS Health sees FY2026 EPS of $7.90-$8.10, versus the consensus of $7.45.

For earnings history and earnings-related data on CVS Health (CVS) click here.

CVS Health (CVS) Tops Q2 EPS by 75c; raises guidance

Wed, 05 Aug 2026 06:32:57 -0400

CVS Health (NYSE: CVS) reported Q2 EPS of $2.58, $0.75 better than the analyst estimate of $1.83. Revenue for the quarter came in at $106.1 billion versus the consensus estimate of $100.03 billion.

GUIDANCE:

CVS Health sees FY2026 EPS of $7.90-$8.10, versus the consensus of $7.45.

For earnings history and earnings-related data on CVS Health (CVS) click here.

Form 8-K CVS HEALTH Corp For: Aug 05

Wed, 05 Aug 2026 06:32:00 -0400

si-local-file:///var/storage/secattach/20260805/26869720.html

Form 8-K CVS HEALTH Corp For: Aug 05

Wed, 05 Aug 2026 06:32:00 -0400

si-local-file:///var/storage/secattach/20260805/26869720.html

CVS HEALTH CORPORATION REPORTS STRONG SECOND QUARTER 2026 RESULTS AND RAISES FULL-YEAR 2026 GUIDANCE

Wed, 05 Aug 2026 06:30:00 -0400

Second quarter total revenues increased to $106.1 billion, up 7.3% year-over-year
Second quarter GAAP diluted EPS of $2.31 and Adjusted EPS of $2.58
Generated year-to-date cash flow from operations of $10.6 billion
Raising full-year 2026 guidance:
- GAAP diluted EPS guidance range to $6.84 to $7.04 from $6.24 to $6.44
- Adjusted EPS guidance range to $7.90 to $8.10 from $7.30 to $7.50
- Cash flow from operations guidance to at least $11.5 billion from at least $9.5 billion